Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Hanna

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
World Journal of Clinical Cases|April 17, 2015
Importance of cardiological evaluation for first seizuresHo Choong, Ibrahim Hanna, Roy Beran
Journal of Paediatrics and Child Health|February 1, 2011
Basilar artery occlusion in a 14-year old female successfully treated with acute intravascular intervention: case report and review of the literatureSanjeev R Taneja, Ibrahim Hanna, Anna Holdgate, et al.
Journal of Cardiovascular Electrophysiology|October 12, 2013
Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE studyMohammad Saeed, Ibrahim Hanna, Dionyssios Robotis, et al.
Neuroepidemiology|May 1, 2010
Validation of emergency and final diagnosis coding in transient ischemic attack: South Western Sydney transient ischemic attack studyDarshan Ghia, Peter R Thomas, Dennis J Cordato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1Joshua E Reuss, Sara Kuruvilla, Nofisat Ismaila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2Sonam Puri, Nofisat Ismaila, Ibrahim Hanna Azar, et al.
Heart Rhythm|January 24, 2023
Preclinical evaluation of a third-generation absorbable antibacterial envelopeCharles J Love, Ibrahim Hanna, George Thomas, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion StudiesCharles A Henrikson, M Rizwan Sohail, Helbert Acosta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
World Journal of Clinical Cases|April 17, 2015
Importance of cardiological evaluation for first seizuresHo Choong, Ibrahim Hanna, Roy Beran
Journal of Paediatrics and Child Health|February 1, 2011
Basilar artery occlusion in a 14-year old female successfully treated with acute intravascular intervention: case report and review of the literatureSanjeev R Taneja, Ibrahim Hanna, Anna Holdgate, et al.
Journal of Cardiovascular Electrophysiology|October 12, 2013
Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE studyMohammad Saeed, Ibrahim Hanna, Dionyssios Robotis, et al.
Neuroepidemiology|May 1, 2010
Validation of emergency and final diagnosis coding in transient ischemic attack: South Western Sydney transient ischemic attack studyDarshan Ghia, Peter R Thomas, Dennis J Cordato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1Joshua E Reuss, Sara Kuruvilla, Nofisat Ismaila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2Sonam Puri, Nofisat Ismaila, Ibrahim Hanna Azar, et al.
Heart Rhythm|January 24, 2023
Preclinical evaluation of a third-generation absorbable antibacterial envelopeCharles J Love, Ibrahim Hanna, George Thomas, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion StudiesCharles A Henrikson, M Rizwan Sohail, Helbert Acosta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Pageof 2